Kaitlyn Bader, Senior Editor

Based on the positive topline phase 3 results, Journey Medical plans to submit a New Drug Application to the FDA in the second half of 2023.

Incyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.

Bush revealed what she is looking forward to in the coming year and the goals she wants to accomplish.

Bunick presented 3 sessions at the 2023 World Congress of Dermatology meeting in Singapore.

As the 25th World Congress of Dermatology winds down this week, Chovatiya shares highlights from his sessions in Singapore.

A poster presentation from the 19th Annual Skin of Color Society Scientific Symposium analyzed the differences in presentation of cutaneous melanoma among Asian American and Pacific Islander patients.

New pharmacokinetic phase 3 data will be presented at the 2023 Society for Pediatric Dermatology meeting next week.

Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.

ICYMI, this week we had stories about ritlecitinib approved for adolescents with severe alopecia areata, harmful social media skin care trends, artificial intelligence in dermatology, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are popular for the month of June.

Learn more about the in-depth topics covered in the June 2023 Frontline Forum acne supplement of Dermatology Times®.

Learn more about the in-depth topics covered in the June 2023 issue of Dermatology Times®.

Sanofi’s investigational anti-OX40-ligand monoclonal antibody showed statistically significant improvement in signs and symptoms of AD in adults.

Renata Block, PA-C; Raj Chovatiya, MD, PhD; and Zoe Diana Draelos, MD, discuss their optimism and concerns surrounding the increased use of artificial intelligence in dermatology.

This week's edition of the Mainstream Patient features stories about barrier repair products for dry skin, face mapping for acne, how to reapply sunscreen over makeup, and more.

Sydney Givens, PA-C, reviews how she discusses cosmeceuticals with her patients and what resources she offers.

Dermatology Times had the opportunity to speak with numerous leading KOLs in the industry, live and virtually, at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

This week's edition of the Mainstream Patient features stories about tinted sunscreens that don't leave a white cast, laundry detergent for sensitive skin, UPF clothing for summer, and more.

ICYMI, this week we had stories about evolving research and treatment options for plaque psoriasis, the role of dermatology PAs, tazarotene lotion for acne, and more.

Lauren Miller, MPAS, PA-C, and Tj Chao, MPAS, PA-C, review how they discuss available treatment options for their plaque psoriasis patients in a recent DermView series.

If you weren’t able to attend Fall Clinical for PAs and NPs or want to review our latest coverage and interviews, our full recap has you covered.

A poster presentation from the Fall Clinical Dermatology Conference for PAs and NPs evaluated the safety and efficacy of tazarotene for acne patients with skin of color.

Roger Ceilley, MD, reviewed his best tips for ensuring the best patient outcomes after surgical procedures at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the final day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Cameron guided attendees at the Fall Clinical Dermatology Conference for PAs and NPs on his treatment considerations for psoriasis and pigmentary disorders during his 2 sessions.

Zeichner reviewed his top 3 acne treatment pearls at the Fall Clinical Dermatology Conference for PAs and NPs.

Stein Gold reviewed biologics and JAK inhibitors for AD at Fall Clinical for PAs and NPs, as well as topical and oral agents for tough acne.

Reynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.

Catch up on coverage from the second day of the 2023 Fall Clinical Dermatology Conference for PAs and NPs.

Givens presented tips for all dermatology providers to consider at the 2023 Fall Clinical Dermatology Conference for PAs and NPs.